Genetic variants in FH (complement factor H) were reported to associate with susceptibility to systemic lupus erythematosus (SLE). This study proposed that the genetic defects of FH in the susceptibility and in the development of lupus nephritis might be different.
Methods
This study enrolled 334 lupus nephritis patients, 269 SLE patients without clinical renal involvement and 350 controls. Two-step genotyping was performed. First, all the exons of the FH gene were fully sequenced in 100 lupus nephritis patients and 100 healthy controls. Second, genotyping of three common variants reported to be functional, rs1061170, rs800292 and rs6677604, was conducted in all the recruited individuals. Further, analysis of their associations with SLE/lupus nephritis susceptibility and the clinico-pathological parameters in the lupus nephritis group was performed.
Results
No significant differences were observed in allele and genotype frequencies of the three single nucleotide polymorphisms between lupus patients and controls. There was a significantly higher ratio of CC/CT genotypes of rs1061170 in lupus nephritis patients with class III than in the other two classes (class III vs. class IV vs. class V: 21.0% vs. 9.7% vs. 9.4%; P = .044). The rs6677604-GG genotype was observed to be associated with the absence of anti-ds DNA antibody (P = .021), and the rs800292-TT genotype was associated with a higher level of circulating C3 (P = 0.20) in lupus nephritis.
Conclusion
In an independent cohort, this is the first genetic association analysis focusing on FH genetic variants in Chinese lupus nephritis patients. It was found that the variants in the FH gene might affect the histopathologic subtypes and some clinical features of the disease.
CrispínJCLiossisSNKis-TothKet al.Pathogenesis of human systemic lupus erythematosus: Recent advances. Trends Mol Med2010; 16: 47–57.
3.
MohanCPuttermanC. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol2015; 11: 329–341.
4.
SalmonJEMillardSSchachterLAet al.Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African-Americans. J Clin Invest1996; 97: 1348–1354.
5.
EdbergJC. Genetic linkage and association of Fcγ receptor IIIA (CD16A) on chromosome 1q23 with human systemic lupus erythematosus. Arthritis Rheum2002; 46: 2132–2140.
6.
BuyonJPTameriusJOrdoricaSYoungBAbramsonSB. Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy. Arthritis Rheum1992; 35: 55–61.
7.
KerrLDAdelsbergBRSchulmanPSpieraH. Factor B activation products in patients with systemic lupus erythematosus. A marker of severe disease activity. Arthritis Rheum1989; 32: 1406–1413.
8.
NagyGBrózikMVargaLet al.Usefulness of detection of complement activation products in evaluating SLE activity. Lupus2000; 9: 19–25.
9.
MathernDRHeegerPS. Molecules great and small: The complement system. Clin J Am Soc Nephrol2015; 10: 1636–1650.
10.
PandaAKParidaJRTripathyRPattanaikSSRavindranBDasBK. Mannose binding lectin: A biomarker of systemic lupus erythematosus disease activity. Arthritis Res Ther2012; 14: R218–R218.
11.
SatoNOhsawaINagamachiSet al.Significance of glomerular activation of the alternative pathway and lectin pathway in lupus nephritis. Lupus2011; 20: 1378–1386.
12.
BuyonJPTameriusJBelmontHMAbramsonSB. Assessment of disease activity and impending flare inpatients with systemic lupus erythematosus: Comparison of the use of complement split products and conventional measurements of complement. Arthritis Rheum1992; 35: 1028–1037.
13.
Rodríguez de CórdobaSEsparza-GordilloJGoicoechea de JorgeELopez-TrascasaMSánchez-CorralP. The human complement factor H: Functional roles, genetic variations and disease associations. Mol Immunol2004; 41: 355–367.
14.
AnsariMMcKeiguePMSkerkaCet al.Genetic influences on plasma FH and FHR1 concentrations and the role in susceptibility to age-related macular degeneration. Hum Mol Genet2013; 22: 4857–4869.
15.
ManuelianTHellwageJMeriSet al.Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. J Clin Invest2003; 111: 1181–1190.
16.
AppelGBCookHTHagemanGet al.Membranoproliferative glomerulonephritis type II (dense deposit disease): An update. J Am Soc Nephrol2005; 16: 1392–1403.
17.
KirylukKLiYSanna-CherchiSet al.Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet2012; 8: e1002765–e1002765.
18.
BraiMMisianoGMaringhiniSCutajaIHauptmannG. Combined homozygous factor H and heterozygous C2 deficiency in an Italian family. J Clin Immunol1988; 8: 50–56.
19.
BaoLHaasMQuiggRJ. Complement factor H deficiency accelerates development of lupus nephritis. J Am Soc Nephrol2011; 22: 285–295.
20.
ZhaoJWuHKhosraviMet al.Association of genetic variants in complement factor H and factor H-related genes with systemic lupus erythematosus susceptibility. PLoS Genet2011; 7: e1002079–e1002079.
21.
WangFMYuFTanYSongDZhaoMH. Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis. Rheumatology (Oxford)2012; 51: 2269–2277.
22.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725–1725.
23.
MillerSADykesDDPoleskyHF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res1988; 16: 1215–1215.
24.
BombardierCGladmanDDUrowitzMBCaronDChangCH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum1992; 35: 630–640.
25.
WeeningJJD’AgatiVDSchwartzMMet al.The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int2004; 65: 521–530.
26.
AustinHA3rdMuenzLRJoyceKMAntonovychTTBalowJE. Diffuse proliferative lupus nephritis: Identification of specific pathologic features affecting renal outcome. Kidney Int1984; 25: 689–695.
27.
DengYTsaoBP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol2010; 6: 683–692.
28.
HerbertAPDeakinJASchmidtCQet al.Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism. J Biol Chem2007; 282: 18960–18968.
29.
HeckerLAEdwardsAORyuEet al.Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. Hum Mol Genet2010; 19: 209–215.
30.
LefflerJHerbertAPNorströmEet al.Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells. J Biol Chem2010; 285: 3766–3776.
31.
SjöbergAPTrouwLAClarkSJet al.The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells. J Biol Chem2007; 282: 10894–10900.
32.
ClarkSJHigmanVAMulloyBet al.His-384 allotypic variant of factor H associated with age-related macular degeneration has different heparin binding properties from the non-disease-associated form. J Biol Chem2006; 281: 24713–24720.
33.
HagemanGSAndersonDHJohnsonLVet al.A common haplotype in the complement regulatory gene factor H (HF1/FH) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sci USA2005; 102: 7227–7232.
34.
ClarkSJBishopPN. Role of factor H and related proteins in regulating complement activation in the macula, and relevance to age-related macular degeneration. J Clin Med2015; 4: 18–31.
35.
LaineMJarvaHSeitsonenSet al.Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J Immunol2007; 178: 3831–3836.
36.
WangFMSongDPangYSongYYuFZhaoMH. The dysfunctions of complement factor H in lupus nephritis. Lupus2016; 25: 1328–1340.
37.
SchwartzMMKawalaKSCorwinHLLewisEJ. The prognosis of segmental glomerulonephritis in systemic lupus erythematosus. Kidney Int1987; 32: 274–279.
38.
KorbetSMLewisEJSchwartzMMReichlinMEvansJRohdeRD. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis2000; 35: 904–914.
39.
NajafiCCKorbetSMLewisEJet al.Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int2001; 59: 2156–2163.
40.
ServaisANoëlLHRoumeninaLTet al.Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies. Kidney Int2012; 82: 454–464.
41.
TruedssonLBengtssonAASturfeltG. Complement deficiencies and systemic lupus erythematosus. Autoimmunity2007; 40: 560–566.
42.
BaoLQuiggRJ. Complement in lupus nephritis: The good, the bad, and the unknown. Semin Nephrol2007; 27: 69–80.
43.
ClarkSJRidgeLAHerbertAPet al.Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. J Immunol2013; 190: 2049–2057.
44.
HainesJLHauserMASchmidtSet al.Complement factor H variant increases the risk of age-related macular degeneration. Science2005; 308: 419–421.
45.
ZhuLZhaiYLWangFMet al.Variants in complement factor H and complement factor H-related protein genes, FHR3 and FHR1, affect complement activation in IgA nephropathy. J Am Soc Nephrol2015; 26: 1195–1204.
46.
HughesAEOrrNEsfandiaryHDiaz-TorresMGoodshipTChakravarthyU. A common FH haplotype, with deletion of FHR1 and FHR3, is associated with lower risk of age-related macular degeneration. Nat Genet2006; 38: 1173–1177.
47.
HagemanGSHancoxLSTaiberAJet al.Extended haplotypes in the complement factor H (FH) and FH-related (FHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications. Ann Med2006; 38: 592–604.
